Physician profile
John B Logan
NPI 1538135868
$12,238.86
in general payments reported to CMS, 2019-2025
13 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $303 · 2021: $5,727 · 2022: $1,196 · 2023: $2,605 · 2024: $1,701 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,850 · Travel and Lodging: $1,774 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.38 |
| Travel and Lodging | $1,773.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $810.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $8,177.36 | 2019-2025 | Optimesh Expandable Interbody Fusion System |
| Abbott Laboratories | $2,598.62 | 2023-2025 | Proclaim, Eterna |
| Spineart USA INC | $682.91 | 2020-2023 | Scarlet Al-T |
| Spinal Elements, INC. | $154.50 | 2024 | |
| Integrity Implants INC. | $138.02 | 2019-2022 | |
| Heron Therapeutics, INC. | $114.99 | 2024 | Aponvie, Zynrelef |
| Choice Spine, LLC | $113.48 | 2019 | |
| Stryker Corporation | $72.21 | 2019 | |
| Augmedics INC. | $71.23 | 2024 | Xvision |
| Orthofix Medical, INC. | $69.92 | 2020 | |
| Si-Bone, INC. | $27.55 | 2025 | |
| Medtronic, INC. | $16.61 | 2025 | Mazor X System |
| Forte Bio-Pharma LLC | $1.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$938,270.56 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.